Current role
Biotechnology · Healthcare
Board Member
2021-01-01–present
Kathleen Scott
Board Member
Dermata Therapeutics, Inc. (DRMA)Equibles does not estimate personal net worth.
Get an email with a short summary when Dermata Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DRMA alertsAbout Kathleen Scott
Kathleen Scott is recorded as Board Member at Dermata Therapeutics, Inc. (DRMA) since January 1, 2021. The newest filing on record that lists Kathleen Scott as Board Member at Dermata Therapeutics, Inc. (DRMA) is dated April 17, 2026. Dermata Therapeutics, Inc. reported in an 8-K filed May 7, 2024 that Kathleen Scott was appointed Class III director, effective May 7, 2024. Dermata Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dermata Therapeutics, Inc. includes Gerald T. Proehl (CEO and Board Member), Kyri K. Van Hoose (CFO), Kyri Van Hoose (CFO) and 7 others.
“The election of Gerald T. Proehl, Wendell Wierenga, Ph.D., and Kathleen Scott as Class III directors to hold office for a term of three years, until their successor is duly elected and qualified or they are otherwise unable to complete their term.”
Affiliation history
-
Current
2021-01-01–present
Last confirmed April 17, 2026
Company network
Leadership on record at Dermata Therapeutics, Inc.
- Gerald T. Proehl CEO, Board Member
- Kyri K. Van Hoose CFO
- Kyri Van Hoose CFO
- Andrew Sandler Board Member
- Brittany Bradrick Board Member
- David Hale Board Member
- Steven Mento Board Member
- Steven Mento, Ph.D. Board Member
- To approve Board Member
- Wendell Wierenga Board Member